Neuroimaging and Neurocognitive Outcomes in Older Patients with Multiple Myeloma Treated with Chemotherapy and Autologous Stem Cell Transplantation

Mostrar otras versiones (1)

BACKGROUND: Many patients with hematological malignancies treated with stem cell transplantation (SCT) experience cognitive dysfunction. However, few studies have investigated treatment-related neurotoxicity in older adults with multiple myeloma (MM) treated with high dose chemotherapy (HDC) and aut...

Descripción completa

Detalles Bibliográficos
Autores principales: Correa, Denise D., Vachha, Behroze A., Baser, Raymond E., Koch, Adrian, Wong, Phillip, Gohel, Suril, Giralt, Sergio, Root, James C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104268/
https://www.ncbi.nlm.nih.gov/pubmed/37066224
http://dx.doi.org/10.21203/rs.3.rs-2733807/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104268/
https://www.ncbi.nlm.nih.gov/pubmed/37066224
http://dx.doi.org/10.21203/rs.3.rs-2733807/v1

Ejemplares similares